the Global Lung cancer screening software Market Size is expected to grow from USD 1.475 billion in 2024 to USD 5.38 billion by 2035, at a CAGR of 13.81% during the forecast period 2025-2035.

The global lung cancer screening software market refers to the industry developing software tools that assist in early detection of lung cancer using medical imaging, especially low-dose CT scans. These solutions use AI and analytics to identify nodules, support diagnosis, and improve screening efficiency in healthcare facilities.

This comprehensive market research report provides an in-depth analysis of the Lung Cancer Screening Software market, with a focused evaluation of industry developments through 2025. The study delivers detailed insights into current market dynamics, emerging trends, growth drivers, competitive landscape, future strategic outlook, and the evolving regulatory key segments.

The Global Lung Cancer Screening Software Market Report identifies emerging business opportunities while supporting informed strategic and tactical decision-making. Designed for stakeholders operating in a highly competitive and rapidly evolving landscape, this study delivers up-to-date market intelligence essential for tracking performance, mitigating risks, and driving sustainable growth and profitability.

Key Players in global lung cancer screening software market

1. Nuance Communications, Inc.
2. Eon
3. Koninklijke Philips N.V.
4. Siemens Healthineers AG
5. PenRad Technologies, Inc.
6. MagView
7. Voxel Cloud
8. FUJIFILM Holdings Corporation
9. Medtronic
10. GE HealthCare Technologies Inc.
11. Qure.ai
12. Optellum
13. Lunit
14. Canon Medical Systems Corporation
15. Volpara Solutions Limited

Our expert team is consistently working on updated data and information on the key player's related business processes that value the market for future strategies and predictions

Get Access to a Free Copy of Our Latest Sample Report - https://www.decisionsadvisors.com/request-sample/DAR4696

Market Segmentation:

By Type

• Computer-Assisted Screening Software
• Traditional Screening Software

By Deployment Mode

• Cloud-Based Solutions
• On-Premise Solutions
• Web-Based Solutions

Key Insights Covered in the Global Lung Cancer Screening Software Market Size & Industry Forecast Report (2020–2035):

1. Detailed analysis of the Global Lung Cancer Screening Software Market Size, production capacity, utilization rate, output trends, capital investment patterns, and regulatory landscape, along with comprehensive profiles of leading market players.

2. Thorough assessment of Lung Cancer Screening Software Market Growth, revenue analysis, historical performance, and forward-looking projections across major regional markets.

3. In-depth Lung Cancer Screening Software Industry Analysis covering competitive landscape, company market share, pricing trends, and future opportunity mapping.

4. Strategic evaluation of recent developments including mergers & acquisitions, partnerships, collaborations, joint ventures, geographic expansions, and product launches shaping the Lung Cancer Screening Software Market Share.

5. Comprehensive value chain and supply chain analysis highlighting raw material sourcing, distribution channels, and end-user segmentation.

6. Regional regulatory framework assessment and policy impact analysis influencing the Lung Cancer Screening Software Industry Forecast across North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.

7. Coverage of technological advancements, product innovations, R&D investments, automation trends, and digital transformation influencing long-term Global Lung Cancer Screening Software Market Growth.

Buy this report now:- https://www.decisionsadvisors.com/checkout/select-licence?report_id=DAR4696

Industry Developments:

In February 2026, Median Technologies announced that eyonis LCS, an AI-based lung cancer screening device, delivers 93.3% sensitivity and 92.4% specificity in low-dose CT analysis. U.S. authorization and the NT-APC 1508 reimbursement pathway are expected to support nationwide screening expansion for 14.5 million eligible individuals.

In February 2026, RevealDx announced that the U.S. Food and Drug Administration cleared RevealAI-Lung, an AI-based software that characterizes lung nodules using a malignancy similarity index to support radiologists’ decisions. Validated on more than 1,500 patients, the solution integrates with PACS systems and is reimbursable by Medicare.

In November 2025, Yashoda Hospital, with Qure.ai and AstraZeneca, launched an AI-enabled Lung Nodule Clinic. Over 17,000 chest X-rays analyzed identified 960 nodules, with 77 patients referred for CT scans, improving early detection of lung cancer and other diseases.

Regional Analysis for Lung Cancer Screening Software Market:

✫ North America: (U.S., Canada, Mexico)
✫ Europe: (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
✫ Asia-Pacific: (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
✫ South America: (Colombia, Brazil, Argentina, Rest of South America)
✫ Middle East & Africa: (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Benefits of the Report:

⏩ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.
⏩ Top-down and bottom-up approach for regional analysis
⏩ Porter’s five forces model gives an in-depth analysis of buyers and suppliers, threats of new entrants & substitutes and competition amongst the key market players.
⏩ By understanding the value chain analysis, the stakeholders can get a clear and detailed picture of this Market

Frequently asked questions:

➥ What is the market size of the Lung Cancer Screening Software market?
➥ What is the market growth rate of the Lung Cancer Screening Software market?
➥ What are the Lung Cancer Screening Software market opportunities and threats faced by the vendors in the global Lung Cancer Screening Software Industry?
➥ Which application/end-user or product type may seek incremental growth prospects? What is the market share of each type and application?
➥ What focused approach and constraints are holding the Lung Cancer Screening Software market?
➥ What are the different sales, marketing, and distribution channels in the global industry?

Unlock the full report now! @ https://www.decisionsadvisors.com/reports/lung-cancer-screening-software-market

About the Decisions Advisors

Decisions Advisors is a comprehensive market research and consulting company that provides actionable insights based on data. We deal with businesses from various industries and deliver a market intelligence, competitive analysis, forecasting, and bespoke consulting. We also conduct bespoke consulting for our clients.

We provides well-supported advice and intelligence on how businesses can operate in a given market and succeed in achieving their goals.

Contact Us:

Company Name: Decision Advisors

Email: [email protected]

Phone: +1 303 800 4326 (US)

Follow Us: LinkedIn | Facebook | Twitter